John Posner
Stamford Street
London, ENG, United Kingdom
London, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Intravesical antimicrobial administration for urinary tract infections via a dedicated catheter.
Journal: British journal of clinical pharmacology
Published: May 20, 2025
Phase 1 safety, tolerability, pharmacokinetics and pharmacodynamic results of KCL-286, a novel retinoic acid receptor-β agonist for treatment of spinal cord injury, in male healthy participants.
Journal: British journal of clinical pharmacology
Published: April 20, 2023
Serum amyloid A-A potential therapeutic target for hyper-inflammatory syndrome associated with COVID-19.
Journal: Frontiers in medicine
Published: January 01, 2023
Revitalising cancer trials post-pandemic: time for reform.
Journal: British journal of cancer
Published: July 14, 2022
Monoclonal Antibodies: Past, Present and Future.
Journal: Handbook of experimental pharmacology
Published: December 11, 2019
Pegvaliase for the treatment of phenylketonuria: A pivotal, double-blind randomized discontinuation Phase 3 clinical trial.
Journal: Molecular genetics and metabolism
Published: January 14, 2018
Response from John Posner, author of commentary.
Journal: British journal of clinical pharmacology
Published: November 23, 2012
Optimizing the dose of dabigatran etexilate.
Journal: British journal of clinical pharmacology
Published: June 09, 2012
Showing 1-9 of 9
Last Updated: 09/26/2026